HHS and its agencies "help health care providers and the public learn about and respond to public health incidents and ...
As part of the Inflation Reduction Act, price negotiations with manufacturers will begin this year, with reduced prices ...
Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...
Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...
HealthDay on MSN3d
Medicare to Negotiate Prices for 15 More Drugs, Including OzempicMedicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for older adults and people with disabilities.
Under the secretary’s leadership, the multiple agencies that constitute HHS oversee the financing of Medicare and Medicaid, conduct research to improve care quality, monitor health care fraud ...
The U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), has ...
The Centers for Medicare & Medicaid Services announced 15 new drugs it wants to lower the cost for, including popular, but ...
Robert F. Kennedy Jr. is set to appear before the Senate Finance Committee for the first of two confirmation hearings as Trump’s nominee for health secretary.
The talks around drugs including Novo Nordisk’s Wegovy, GSK’s Trelegy Ellipta, and Pfizer’s Xtandi will set Medicare prices ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback